Intra-uterine insemination for unexplained subfertility

被引:27
|
作者
Veltman-Verhulst, Susanne M. [1 ]
Hughes, Edward [2 ]
Ayeleke, Reuben Olugbenga [3 ]
Cohlen, Ben J. [4 ]
机构
[1] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Room F5-126,POB 85500, NL-3508 GA Utrecht, Netherlands
[2] McMaster Univ, Dept Obstet & Gynaecol, ONE Fertil, Hamilton, ON, Canada
[3] Univ Auckland, Dept Obstet & Gynaecol, Auckland, New Zealand
[4] Isala Clin, Dept Obstet & Gynaecol, Zwolle, Netherlands
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2016年 / 02期
关键词
Pregnancy Rate; Coitus; Fertile Period [physiology; Infertility [therapy; Insemination; Artificial [adverse effects; methods; Live Birth [epidemiology; Ovulation Induction [adverse effects; Pregnancy; Multiple; Randomized Controlled Trials as Topic; Time Factors; Female; Humans; Male; CONTROLLED OVARIAN HYPERSTIMULATION; HUMAN MENOPAUSAL GONADOTROPIN; ORDER MULTIPLE PREGNANCY; OVULATION INDUCTION; CLOMIPHENE CITRATE; TIMED INTERCOURSE; INTERMEDIATE PROGNOSIS; EXPECTANT MANAGEMENT; SUPEROVULATED CYCLES; NATURAL INTERCOURSE;
D O I
10.1002/14651858.CD001838.pub5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Intra-uterine insemination (IUI) is a widely used fertility treatment for couples with unexplained subfertility. Although IUI is less invasive and less expensive thAppendixan in vitro fertilisation (IVF), the safety of IUI in combination with ovarian hyperstimulation (OH) is debated. The main concern about IUI treatment with OH is the increase in multiple pregnancy rate. This is an update of a Cochrane review (Veltman-Verhulst 2012) originally published in 2006 and updated in 2012. Objectives To determine whether, for couples with unexplained subfertility, IUI improves the live birth rate compared with timed intercourse (TI), or expectant management, both with and without ovarian hyperstimulation (OH). Search methods We searched the Cochrane Gynaecology and Fertility (formerly Cochrane Menstrual Disorders and Subfertility Group) Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, inception to Issue 11, 2015), Ovid MEDLINE, Ovid EMBASE, PsycINFO and trial registers, all from inception to December 2015 and reference lists of articles. Authors of identified studies were contacted for missing or unpublished data. The evidence is current to December 2015. Selection criteria Truly randomised controlled trial (RCT) comparisons of IUI versus TI, in natural or stimulated cycles. Only couples with unexplained subfertility were included. Data collection and analysis Two review authors independently performed study selection, quality assessment and data extraction. We extracted outcomes, and pooled data and, where possible, we carried out subgroup and sensitivity analyses. Main results We included 14 trials including 1867 women. IUI versus TI or expectant management both in natural cycle Live birth rate (all cycles) There was no evidence of a difference in cumulative live births between the two groups (Odds Ratio (OR) 1.60, 95% confidence interval (CI) 0.92 to 2.78; 1 RCT; n = 334; moderate quality evidence). The evidence suggested that if the chance of a live birth in TI was assumed to be 16%, that of IUI would be between 15% and 34%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rate between the two treatment groups (OR 0.50, 95% CI 0.04 to 5.53; 1 RCT; n = 334; moderate quality evidence). IUI versus TI or expectant management both in stimulated cycle Live birth rate (all cycles) There was no evidence of a difference between the two treatment groups (OR 1.59, 95% CI 0.88 to 2.88; 2 RCTs; n = 208; I-2 = 72%; moderate quality evidence). The evidence suggested that if the chance of achieving a live birth in TI was assumed to be 26%, the chance of a live birth with IUI would be between 23% and 50%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rates between the two treatment groups (OR 1.46, 95% CI 0.55 to 3.87; 4 RCTs, n = 316; I-2 = 0%; low quality evidence). IUI in a natural cycle versus IUI in a stimulated cycle Live birth rate (all cycles) An increase in live birth rate was found for women who were treated with IUI in a stimulated cycle compared with those who underwent IUI in natural cycle (OR 0.48, 95% CI 0.29 to 0.82; 4 RCTs, n = 396; I-2 = 0%; moderate quality evidence). The evidence suggested that if the chance of a live birth in IUI in a stimulated cycle was assumed to be 25%, the chance of a live birth in IUI in a natural cycle would be between 9% and 21%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rate between the two treatment groups (OR 0.33, 95% CI 0.01 to 8.70; 2 RCTs; n = 65; low quality evidence). IUI in a stimulated cycle versus TI or expectant management in a natural cycle Live birth rate (all cycles) There was no evidence of a difference in live birth rate between the two treatment groups (OR 0.82, 95% CI 0.45 to 1.49; 1 RCT; n = 253; moderate quality evidence). The evidence suggested that if the chance of a live birth in TI or expectant management in a natural cycle was assumed to be 24%, the chance of a live birth in IUI in a stimulated cycle would be between 12% and 32%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rate between the two treatment groups (OR 2.00, 95% CI 0.18 to 22.34; 2 RCTs; n = 304; moderate quality evidence). IUI in natural cycle versus TI or expectant management in stimulated cycle Live birth rate (all cycles) There was evidence of an increase in live births for IUI (OR 1.95, 95% CI 1.10 to 3.44; 1 RCT, n = 342; moderate quality evidence). The evidence suggested that if the chance of a live birth in TI in a stimulated cycle was assumed to be 13%, the chance of a live birth in IUI in a natural cycle would be between 14% and 34%. Multiple pregnancy rate There was no evidence of a difference in multiple pregnancy rate between the groups (OR 1.05, 95% CI 0.07 to 16.90; 1 RCT; n = 342; moderate quality evidence). The quality of the evidence was assessed using GRADE methods. Quality ranged from low to moderate, the main limitation being imprecision in the findings for both live birth and multiple pregnancy.
引用
收藏
页数:90
相关论文
共 50 条
  • [31] The effect of intra-uterine devices on the reproductive physiology and behaviour of pony mares
    Argo, C. M.
    Turnbull, E. B.
    VETERINARY JOURNAL, 2010, 186 (01): : 39 - 46
  • [32] The role of sperm DNA fragmentation testing in predicting intra-uterine insemination outcome: A systematic review and meta-analysis
    Sugihara, Alessa
    Van Avermaete, Freya
    Roelant, Ella
    Punjabi, Usha
    De Neubourg, Diane
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 244 : 8 - 15
  • [33] Use of reticulin stain in the diagnosis of intra-uterine gestation
    Stewart, Colin J. R.
    Little, Leonie
    PATHOLOGY, 2008, 40 (04) : 365 - 371
  • [34] Chlorophyllin in the intra-uterine development of mice exposed or not to cyclophosphamide
    Leite, Vessia Silva
    Oliveira, Rodrigo Juliano
    Nakamura Kanno, Tatiane Yumi
    Mantovani, Mario Sergio
    Moreira, Estefania Gastaldello
    Sparca Salles, Maria Jose
    ACTA SCIENTIARUM-HEALTH SCIENCES, 2013, 35 (02) : 201 - 210
  • [35] Intra-uterine growth retardation: Also a concern for the internist!
    Pourrat, O.
    Pierre, F.
    REVUE DE MEDECINE INTERNE, 2012, 33 (11): : 603 - 606
  • [36] Common risk factors for unexplained intra uterine death
    Shaikh, Shazia
    Akhtar, Tanweer
    Zia, Basma
    Soomro, Shabana
    Sonia
    Memon, Naila
    RAWAL MEDICAL JOURNAL, 2019, 44 (04): : 705 - 708
  • [37] Role of antral follicle count in controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unexplained subfertility
    Erdem, Mehmet
    Erdem, Ahmet
    Guler, Ismail
    Atmaca, Songul
    FERTILITY AND STERILITY, 2008, 90 (02) : 360 - 366
  • [38] Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial
    Danhof, N. A.
    van Wely, M.
    Repping, S.
    Koks, C.
    Verhoeve, H. R.
    de Bruin, J. P.
    Verberg, M. F. G.
    van Hooff, M. H. A.
    Cohlen, B. J.
    van Heteren, C. F.
    Fleischer, K.
    Gianotten, J.
    van Disseldorp, J.
    Visser, J.
    Broekmans, F. J. M.
    Mol, B. W. J.
    van der Veen, F.
    Mochtar, M. H.
    HUMAN REPRODUCTION, 2018, 33 (10) : 1866 - 1874
  • [39] Intra-uterine adhesions and fertility outcome: how to optimize success?
    Kodaman, Pinar H.
    Arici, Aydin
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2007, 19 (03) : 207 - 214
  • [40] Elective Delivery at Term after a Previous Unexplained Intra-Uterine Fetal Death: Audit of Delivery Outcome at Tygerberg Hospital, South Africa
    Gebhardt, Stefan
    Oberholzer, Leana
    PLOS ONE, 2015, 10 (06):